Stockscreener 앱 받기
1.55
92.43%
0.7445
시장 영업 전:
1.30
-0.25
-16.13%
전일 마감가:
$0.8055
열려 있는:
$1.45
하루 거래량:
268.53M
Relative Volume:
43.88
시가총액:
$53.39M
수익:
-
순이익/손실:
$-20.34M
주가수익비율:
-2.2238
EPS:
-0.697
순현금흐름:
$-15.59M
1주 성능:
+120.08%
1개월 성능:
-8.28%
6개월 성능:
-3.13%
1년 성능:
-48.33%
1일 변동 폭
$1.20
$1.79
1주일 범위
$0.6865
$1.79
52주 변동 폭
$0.54
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.55 | 27.74M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 개시 | Roth Capital | Buy |
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech
FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize
HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Yahoo Finance
HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade
HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io
HeartBeam announces FDA clearance for 12-lead ECG synthesis software - TipRanks
HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright - TipRanks
FDA clears HeartBeam’s at-home arrhythmia assessment tool - Yahoo
Weekly Trades: Is HeartBeam Inc stock recession proofTrade Entry Report & Community Trade Idea Sharing Platform - BỘ NỘI VỤ
Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Benzinga
HeartBeam Receives FDA Clearance for 12-Lead ECG for At-Home Arrhythmia Assessment - marketscreener.com
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - TradingView
HeartBeam Wins FDA Nod for Cable-Free 12-Lead ECG for Home Arrhythmia Assessment - Medical Product Outsourcing
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam : Earnings Documents - marketscreener.com
HeartBeam stock soars after FDA clearance for 12-lead ECG synthesis software - Investing.com Nigeria
Why Is HeartBeam Stock (BEAT) Up Today? - TipRanks
Heartbeam rises after FDA clears its cable‑free ECG software - TradingView
HeartBeam’s 12-lead ECG synthesis software receives FDA clearance By Investing.com - Investing.com Australia
HeartBeam’s 12-lead ECG synthesis software receives FDA clearance - Investing.com India
HeartBeam earns FDA clearance for first-ever cable-free 12-lead ECG for at-home arrhythmia assessment - MassDevice
Why Did BEAT Stock Rocket 72% In Pre-Market Today? - Stocktwits
HC Wainwright & Co. Initiates Coverage of HeartBeam (BEAT) with Buy Recommendation - Nasdaq
An analyst sees good growth prospects for HeartBeam Inc (BEAT) - Setenews
HeartBeam (BEAT) Receives 'Buy' Rating from HC Wainwright & Co. - GuruFocus
HC Wainwright Initiates HeartBeam at Buy With $2.50 Price Target - marketscreener.com
HeartBeam initiated with a Buy at H.C. Wainwright - TipRanks
Will HeartBeam Inc stock deliver shareholder valueWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - BỘ NỘI VỤ
How institutional buying supports HeartBeam Inc. stockEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Why hedge funds are buying HeartBeam Inc. stockEarnings Miss & Technical Entry and Exit Alerts - Newser
Will HeartBeam Inc. stock maintain dividend yieldMarket Rally & Fast Exit Strategy with Risk Control - Newser
What is the fair value of HeartBeam Inc. Equity Warrant stock nowQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
HeartBeam Pursues Regulatory Path After FDA Decision on ECG Software - citybuzz
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - Digital Journal
HeartBeam (BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - NewMediaWire
HeartBeam Outlines Regulatory Strategy Following FDA Decision on ECG Software - citybuzz
HeartBeam Inc (BEAT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Breakout Watch & Fast Gain Swing Alerts - moha.gov.vn
Biotech Minors Make Major Moves On FDA News And Stock Sales - Finimize
HeartBeam’s Strategic Path to Overcome Regulatory Challenges and Secure Buy Rating - TipRanks
Crude Oil Gains 1%; Tilray Brands Shares Plunge - Benzinga
Nasdaq Rises 100 Points; Chagee Shares Gain After Q3 Results - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
HeartBeam Outlines Regulatory Path Following FDA NSE Decision On 12-Lead ECG Synthesis Software - Nasdaq
Is HeartBeam Inc. stock dividend yield sustainableGold Moves & Safe Capital Growth Plans - BỘ NỘI VỤ
What's Behind HeartBeam's Over 40% After-Hours Surge? - Benzinga
HeartBeam, Inc. (BEAT) Stock: Soars as FDA Appeal Strategy Sparks Investor Optimism - parameter.io
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.74%
4.47%
자본화:
|
볼륨(24시간):